Nasus Pharma
$3.07
1
-$0.16-4.95%Friday 20:00
+$0.00+0%Friday 20:10After hours
Statistics
Day High
3.2
Day Low
3.12
52W High
9.5
52W Low
1.98
Volume
1,589
Avg. Volume
-
Mkt Cap
35.96M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Aug 17Expected
Q2 2026
-0.54
-0.21
0.13
0.46
Expected EPS
N/A
Actual EPS
-0.54
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
Show More
CEO
Brendan O'Grady
Employees
7
Country
Israel
ISIN
IL0012181553
Listings
0 Comments
Share your thoughts
FAQs
What is Nasus Pharma stock price today?▼
The current price of NSRX is $3.07 USD — it has decreased by -4.95% in the past 24 hours. Watch Nasus Pharma stock price performance more closely on the chart.
What is Nasus Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange Nasus Pharma stocks are traded under the ticker NSRX.
Is Nasus Pharma stock price growing?▼
NSRX stock has fallen by -12.03% compared to the previous week, the month change is a -21.68% fall, over the last year Nasus Pharma has showed a -60.13% decrease.
What is Nasus Pharma market cap?▼
Today Nasus Pharma has the market capitalization of 35.96M
When is the next Nasus Pharma earnings date?▼
Nasus Pharma is going to release the next earnings report on March 3, 2027.
What were Nasus Pharma earnings last quarter?▼
NSRX earnings for the last quarter are -0.54 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Nasus Pharma have?▼
As of November 2, 2026, the company has 7 employees.
In which sector is Nasus Pharma located?▼
Nasus Pharma operates in the Health & Wellness sector.
When did Nasus Pharma complete a stock split?▼
Nasus Pharma has not had any recent stock splits.
Where is Nasus Pharma headquartered?▼
Nasus Pharma is headquartered in Tel Aviv, Israel.